EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Novel design of dual-action Pt( iv ) anticancer pro-drugs based on cisplatin and derivatives of the tyrosine kinase inhibitors imatinib and nilotinib

Darren Fergal Beirne, Barbara Farkaš, Chiara Donati, Valentina Gandin, Isabel Rozas, Trinidad Velasco-Torrijos, Diego Montagner

Dalton Transactions · 2023

DOI: 10.1039/d3dt02030d ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dalton Transactions, 2023. Verfasst von Darren Fergal Beirne und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Maynooth University, Ireland. diego.montagner@mu.ie. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents, Coordination Complexes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Science Foundation Ireland, Irish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel strategy for the development of Pt(IV) cisplatin-based prodrugs with tyrosine kinase inhibitors (TKi's) containing a detailed theoretical approach, synthesis, chemical characterization and preliminary results as anticancer agents and TKi's

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsAntineoplastic AgentsCoordination ComplexesCisplatinImatinib MesylateTyrosine Kinase InhibitorsPyrimidinesCell Line, Tumor

Substanzen

CisplatinImatinib MesylateProdrugsTyrosine Kinase InhibitorsAntineoplastic AgentsPyrimidinesCoordination Complexes

Autor:innen und Institutionen

  • Department of Chemistry, Maynooth University, Ireland. diego.montagner@mu.ie.
  • School of Chemistry, Trinity College Dublin, Ireland.
  • Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Italy.
  • Kathleen Londsdale Institute for Human Health Research, Maynooth University, Ireland.

Förderung

  • Science Foundation Ireland
  • Irish Research Council

Zitieren

APA

Beirne, D. F., Farkaš, B., Donati, C., Gandin, V., Rozas, I., Velasco-Torrijos, T., & Montagner, D. (2023). Novel design of dual-action Pt( iv ) anticancer pro-drugs based on cisplatin and derivatives of the tyrosine kinase inhibitors imatinib and nilotinib. Dalton Transactions. https://doi.org/10.1039/d3dt02030d

Vancouver

Beirne DF, Farkaš B, Donati C, Gandin V, Rozas I, Velasco-Torrijos T, et al. Novel design of dual-action Pt( iv ) anticancer pro-drugs based on cisplatin and derivatives of the tyrosine kinase inhibitors imatinib and nilotinib. Dalton Transactions. 2023. doi:10.1039/d3dt02030d

BibTeX
@article{Beirne2023,
  author = {Beirne, Darren Fergal and Farkaš, Barbara and Donati, Chiara and Gandin, Valentina and Rozas, Isabel and Velasco-Torrijos, Trinidad and Montagner, Diego},
  title = {Novel design of dual-action Pt( iv ) anticancer pro-drugs based on cisplatin and derivatives of the tyrosine kinase inhibitors imatinib and nilotinib},
  journal = {Dalton Transactions},
  year = {2023},
  doi = {10.1039/d3dt02030d}
}
Kostenlos starten →